Our EUTIFORM^TM technology uses a proprietary oral drug reformulation technology and has been shown to significantly improve solubility of active pharmaceutical ingredients by transforming physical structure without impacting chemical activity, thus maintaining their therapeutic effect. We have reformulated existing pharmaceuticals that have side effect challenges by creating a lower dose proprietary formulation. This would lower dosage required for immuno-suppressed individuals and offer new possibilities for viability of many existing drugs to new markets as well as new drugs under development.  The initial reformulations will be licensed out to big Pharma and to generic drug companies.